Oct 26 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab on Thursday lowered its annual revenue growth forecast, given the uncertain pace of the biopharma sector's recovery and ongoing macro ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Bio-Rad Laboratories (BIO) reports results for the quarter ended March 2025. While this widely-known consensus ...

The gel was stained with ethidium bromide and then imaged using a UV transilluminator (ChemiDoc XRS; Bio-Rad, Richmond, CA, USA). The degradability of the DNFs was evaluated in 10% human serum and ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K.